Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924505 · ClinicalTrials.gov registry record · NA
Preventing Opioid Overdose Mortality in the United States
A NA study, sponsored by RTI International.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03924505 is a NA study that has completed, run by RTI International. The registered enrollment target is 105 participants.
The verdict
NCT03924505, a NA study, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study aims to conduct a randomized controlled trial of 105 syringe services programs (SSPs) throughout the United States to understand the effectiveness of a multifaceted, facilitation-based strategy at advancing naloxone implementation effectiveness within SSPs. Together, these efforts can improve access to naloxone for people at high risk of overdose, thereby improving our nation's response to the opioid overdose epidemic.
Interventions
- OTHER Organize and Mobilize for Implementation Effectiveness
- OTHER Dissemination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2022-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03924505
The ClinicalTrials.gov registry entry for NCT03924505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Organize and Mobilize for Implementation Effectiveness is the first listed.
NCT03924505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03924505 about?
NCT03924505 is a clinical study titled "Preventing Opioid Overdose Mortality in the United States". This study aims to conduct a randomized controlled trial of 105 syringe services programs (SSPs) throughout the United States to understand the effectiveness of a multifaceted, facilitation-based strategy at advancing naloxone implementation effectiveness within SSPs. Together, these efforts can imp...
What is the current status of trial NCT03924505?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2019-09-03. Estimated completion is 2022-03-14.
What interventions are being tested in trial NCT03924505?
The interventions under investigation include: Organize and Mobilize for Implementation Effectiveness (OTHER), Dissemination (OTHER).
Who is sponsoring clinical trial NCT03924505?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.